FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic raloxifene hydrochloride product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

SUPPL AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)